- 5 Resultados
precio mínimo: € 11,75, precio máximo: € 233,00, precio promedio: € 169,50
1
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad Chuang Lu Editor
Pedir
por BarnesandNoble.com
€ 233,00
Pedir
Detalles y envío
Enlace patrocinado

Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad Chuang Lu Editor - libro nuevo

ISBN: 9780470281741

The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of e… Más…

new in stock. Gastos de envío:zzgl. Versandkosten., más gastos de envío
cerrar (X)
2
Enzyme Inhibition in Drug Discovery and Development - Chuang Lu
Pedir
por BookDepository.com
€ 194,60
Envío: € 0,001
Pedir
Detalles del proveedor
Enlace patrocinado

Chuang Lu:

Enzyme Inhibition in Drug Discovery and Development - encuadernado, tapa blanda

ISBN: 9780470281741

Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Más…

Gastos de envío:Versandkostenfrei. (EUR 0.00)
cerrar (X)
3
Enzyme Inhibition in Drug Discovery and Development - Chuang Lu
Pedir
por BookDepository.com
€ 195,00
Envío: € 0,001
Pedir
Detalles del proveedor
Enlace patrocinado
Chuang Lu:
Enzyme Inhibition in Drug Discovery and Development - encuadernado, tapa blanda

ISBN: 9780470281741

Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Más…

Gastos de envío:Versandkostenfrei. (EUR 0.00)
cerrar (X)
4
Pedir
por Biblio.co.uk
$ 14,01
(aprox. € 11,75)
Envío: € 10,901
Pedir
Detalles del proveedor
Enlace patrocinado
Editor-Chuang Lu; Editor-Albert P. Li:
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad - encuadernado, tapa blanda

2010, ISBN: 9780470281741

Wiley, 2010-01-07. Hardcover. Good., Wiley, 2010-01-07, 2.5

Gastos de envío: EUR 10.90 Ergodebooks
cerrar (X)
5
Pedir
por lehmanns.de
€ 213,14
Envío: € 0,001
Pedir
Detalles del proveedor
Enlace patrocinado
Chuang Lu; Albert P. Li:
Enzyme Inhibition in Drug Discovery and Development - encuadernado, tapa blanda

2009, ISBN: 9780470281741

The Good and the Bad, Hardcover, Buch, [PU: John Wiley & Sons Inc]

Gastos de envío:Versand in 10-15 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
cerrar (X)
1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.

Datos bibliográficos del mejor libro coincidente

Detalles del libro
Enzyme Inhibition in Drug Discovery and Development
Autor:
Título:
ISBN:

9780470281741


The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of enzyme inhibition, Enzyme Inhibition in Drug Discovery and Development examines the scientific concepts and experimental approaches related to enzyme inhibition as applied in drug discovery and drug development. With chapters written by over fifty leading experts in their fields, Enzyme Inhibition in Drug Discovery and Development fosters a cross-fertilization of pharmacology, drug metabolism, pharmacokinetics, and toxicology by understanding the "good" inhibitions--desirable pharmacological effects--and "bad" inhibitions--drug-drug interactions and toxicity. The book discusses: * The drug discovery process, including drug discovery strategy, medicinal chemistry, analytical chemistry, drug metabolism, pharmacokinetics, and safety biomarker assessment * The manipulations of drug metabolizing enzymes and transporters as well as the negative consequences, such as drug-drug interactions * The inhibition of several major drug target pathways, such as the GPCR pathway, the NFkB pathway, and the ion channel pathway Through this focused, single-source reference on the fundamentals of drug discovery and development, researchers in drug metabolism and pharmacokinetics (DMPK) will learn and appreciate target biology in drug discovery; discovery biologists and medicinal chemists will also broaden their understanding of DMPK.

Detalles del libro - Enzyme Inhibition in Drug Discovery and Development


EAN (ISBN-13): 9780470281741
ISBN (ISBN-10): 047028174X
Tapa dura
Año de publicación: 2010
Editorial: John Wiley & Sons Inc
854 Páginas
Peso: 1,270 kg
Idioma: eng/Englisch

Libro en la base de datos desde 2010-08-19T05:13:25-05:00 (Mexico City)
Página de detalles modificada por última vez el 2022-02-01T04:38:54-06:00 (Mexico City)
ISBN/EAN: 9780470281741

ISBN - escritura alterna:
0-470-28174-X, 978-0-470-28174-1
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: chuang, chuan
Título del libro: enzyme, development inhibition, the enzymes

Datos del la editorial

Autor: Chuang Lu; Albert P. Li
Título: Enzyme Inhibition in Drug Discovery and Development - The Good and the Bad
Editorial: John Wiley & Sons
868 Páginas
Año de publicación: 2010-01-26
Peso: 1,274 kg
Idioma: Inglés
195,00 € (DE)
Not available (reason unspecified)
165mm x 240mm x 43mm

BB; GB; Hardcover, Softcover / Chemie; Chemie; Pharmakologie u. Pharmazeutische Medizin; Drug Discovery & Development; Enzymes & Receptors; Medical Science; Enzyme u. Rezeptoren; Wirkstoffforschung u. -entwicklung; Enzyme; Chemistry; Medizin; Wirkstoffforschung; Pharmacology & Pharmaceutical Medicine; Chemie; Pharmakologie

PREFACE. CONTRIBUTORS. PART I. DRUG DISCOVERY APPROACHES AND TECHNOLOGIES. 1. The Drug Discovery Process (Gerald T. Miwa). 2. Medicinal Chemistry of the Optimization of Enzyme Inhibitors (Geraldine Harriman, Amy Elder, and Indranath Ghosh). 3. Bioanalytical Technologies in Drug Discovery (Jing-Tao Wu). 4. Safety Biomarkers in Drug Development: Emerging Trends and Implications (Eric R. Fedyk). 5. The Role of Drug Metabolism in Drug Discovery (Tonika Bohnert and Liang-Shang Gan). 6. Applied Pharmacokinetics in Drug Discovery and Development (Hua Yang, Xingrong Liu, Anjaneya Chimalakonda, Zheng Lu, Cuiping Chen, Frank Lee, and Wen Chyi Shyu). PART II. INHIBITION OF THE DRUG METABOLIZING ENZYMES--THE UNDESIRABLE INHIBITION. 7. Enzyme Inhibition and Inactivation: Cytochrome P450 Enzymes (R. Scott Obach). 8. Cytochrome P450 Induction (Edward L. LeCluyse, Michael W. Sinz, Nicola Hewitt, Stephen S. Ferguson, and Jasminder Sahi). 9. Inhibition of Drug-Metabolizing Enzymes in Gastrointestinal Tract and Its Influence on the Drug-Drug Interaction Prediction (Aleksandra Galetin and J. Brian Houston). 10. Enzyme Inhibition in Various In Vitro Systems (Ping Zhou). 11. Cytochrome P450 Degradation and Its Clinical Relevance (Mingxiang Liao, Ping Kang, Bernard P. Murray, and Maria Almira Correia). 12. Complexities of Working with UDP-Glucuronosyltransferases (UGTs): Focus on Enzyme Inhibition (Michael B. Fisher). 13. Evaluation of Inhibitors of Drug Metabolism in Human Hepatocytes (Albert P. Li and Chuang Lu). 14. Grapefruit Juice and Its Constituents as New Esterase Inhibitors (Suresh K. Balani). 15. Transporter-Xenobiotic Interactions: An Important Aspect of Drug Development Studies (Gang Luo, Richard Ridgewell, and Thomas Guenthner). 16. Polymorphisms of Drug Transporters and Their Clinical Implications (Cindy Q. Xia and Johnny J. Yang). 17. Clinical Drug Interactions Due to Metabolic Inhibition: Prediction, Assessment, and Interpretation (Lisa L. von Moltke and David J. Greenblatt). 18. Predicting Interindividual Variability of Metabolic Drug-Drug Interactions: Identifying the Causes and Accounting for Them Using Systems Approach (Amin Rostami-Hodjegan). PART III. INHIBITION OF THE DRUG TARGET ENZYMES--THE DESIRABLE INHIBITION. 19. NF-ºB: Mechanism, Tumor Biology, and Inhibitors (Lenny Dang). 20. G-Protein-Coupled Receptors as Drug Targets (Wenyan Miao and Lijun Wu). 21. Pharmacological Modulation of Ion Channels for the Treatment of Chronic Pain (Yi Liu and Ning Qin). 22. Targeting the mTOR Pathway for Tumor Therapeutics (Wei Chen). 23. HIV-1 Protease Inhibitors as Antiretroviral Agents (Sergei V. Gulnik, Elena Afonina, and Michael Eissenstat). INDEX.

Más, otros libros, que pueden ser muy parecidos a este:

Último libro similar:
9780470538944 Enzyme Inhibition in Drug Discovery and Development (Chuang Lu; Albert P. Li)

< para archivar...